ALLAKOS INC (ALLK)

US01671P1003 - Common Stock

1.025  +0 (+0.49%)

Fundamental Rating

2

Overall ALLK gets a fundamental rating of 2 out of 10. We evaluated ALLK against 588 industry peers in the Biotechnology industry. ALLK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALLK does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALLK has reported negative net income.
In the past year ALLK has reported a negative cash flow from operations.
ALLK had negative earnings in each of the past 5 years.
In the past 5 years ALLK always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -76.23%, ALLK is not doing good in the industry: 69.18% of the companies in the same industry are doing better.
With a Return On Equity value of -110.00%, ALLK perfoms like the industry average, outperforming 43.84% of the companies in the same industry.
Industry RankSector Rank
ROA -76.23%
ROE -110%
ROIC N/A
ROA(3y)-69.83%
ROA(5y)-49.47%
ROE(3y)-91.22%
ROE(5y)-62.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ALLK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALLK has more shares outstanding
Compared to 5 years ago, ALLK has more shares outstanding
There is no outstanding debt for ALLK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -7.66, we must say that ALLK is in the distress zone and has some risk of bankruptcy.
ALLK has a Altman-Z score of -7.66. This is in the lower half of the industry: ALLK underperforms 71.58% of its industry peers.
ALLK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.66
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 4.92 indicates that ALLK has no problem at all paying its short term obligations.
ALLK's Current ratio of 4.92 is in line compared to the rest of the industry. ALLK outperforms 53.77% of its industry peers.
ALLK has a Quick Ratio of 4.92. This indicates that ALLK is financially healthy and has no problem in meeting its short term obligations.
ALLK has a Quick ratio (4.92) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 4.92
Quick Ratio 4.92

More info and screens

1

3. Growth

3.1 Past

ALLK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.48%, which is quite impressive.
EPS 1Y (TTM)61.48%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 25.56% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y42.55%
EPS Next 2Y29.07%
EPS Next 3Y17.77%
EPS Next 5Y25.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALLK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALLK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ALLK's earnings are expected to grow with 17.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.07%
EPS Next 3Y17.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALLK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLAKOS INC

NASDAQ:ALLK (4/25/2024, 12:36:20 PM)

1.025

+0 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap90.07M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.23%
ROE -110%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.92
Quick Ratio 4.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.48%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y42.55%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y